We are live on ! Find out more
ETNB

89bio
ETNB

Delisted

ETNB was delisted on the 29th of October, 2025.

Back to rankings

68 hedge funds and large institutions have $408M invested in 89bio in 2020 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 29 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,000% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 3

480% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 5

90% more capital invested

Capital invested by funds: $215M → $408M (+$193M)

79% more funds holding

Funds holding: 38 → 68 (+30)

3.51% more ownership

Funds ownership: 77.13% → 80.64% (+3.5%)

Holders
68
Holders Change
+30
Holders Change %
+78.95%
% of All Funds
1.37%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
33
Increased
29
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$50M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$27.5M
3
Franklin Resources
Franklin Resources
California
+$14.6M
4
ACP
Acuta Capital Partners
California
+$13.2M
5
Bank of America
Bank of America
North Carolina
+$11.7M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$8.72M
2
VA
VR Adviser
New York
-$5.8M
3
LGM
Logos Global Management
California
-$5.78M
4
Morgan Stanley
Morgan Stanley
New York
-$1.21M
5
JP Morgan Chase
JP Morgan Chase
New York
-$232K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$122M +$50M +1,575,000 +50%
O
2
OrbiMed
New York
$95.7M -$8.72M -275,000 -7%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$46.8M +$27.5M +865,882 +90%
Franklin Resources
4
Franklin Resources
California
$17.6M +$14.6M +460,600 +206%
EAM
5
Eventide Asset Management
Massachusetts
$17.3M +$3.17M +100,000 +17%
Vanguard Group
6
Vanguard Group
Pennsylvania
$14.1M +$9.19M +289,589 +112%
BlackRock
7
BlackRock
New York
$11.2M +$7.03M +221,709 +104%
ACP
8
Acuta Capital Partners
California
$10.7M +$13.2M +417,500 New
Bank of America
9
Bank of America
North Carolina
$9.89M +$11.7M +369,086 +2,247%
IC
10
Ikarian Capital
Texas
$8.73M +$10.8M +340,236 New
VC
11
Vivo Capital
California
$4.7M +$5.81M +183,042 New
JP Morgan Chase
12
JP Morgan Chase
New York
$4.47M -$232K -7,324 -4%
Northern Trust
13
Northern Trust
Illinois
$2.91M +$1.02M +32,132 +40%
DCM
14
DAFNA Capital Management
California
$2.83M +$2.85M +90,000 +439%
PHP
15
Parkman Healthcare Partners
Connecticut
$2.82M +$3.49M +110,000 New
AGM
16
Alpine Global Management
New York
$2.68M +$3.32M +104,534 New
Geode Capital Management
17
Geode Capital Management
Massachusetts
$2.52M +$861K +27,137 +38%
PCM
18
Pentwater Capital Management
Florida
$2.39M +$2.95M +93,000 New
State Street
19
State Street
Massachusetts
$2.15M +$1.02M +32,126 +62%
Alyeska Investment Group
20
Alyeska Investment Group
Illinois
$2.11M +$2.61M +82,376 New
N
21
Nuveen
North Carolina
$1.71M +$2.11M +66,676 New
Janus Henderson Group
22
Janus Henderson Group
United Kingdom
$1.56M +$1.92M +60,650 New
SFM
23
Sphera Funds Management
Israel
$1.51M +$1.87M +58,939 New
Royal Bank of Canada
24
Royal Bank of Canada
Ontario, Canada
$1.5M +$1.25M +39,354 +208%
Two Sigma Investments
25
Two Sigma Investments
New York
$1.45M +$1.79M +56,560 New
1
2 3

ETNB Hedge Fund Activity: Q3 2020 in Review

68 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in 89bio (ETNB) for Q3 2020, worth a combined $408M — up 90% from $215M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new ETNB positions and 3 closed out — a net gain of 30 holders — while 29 added to existing stakes and 5 trimmed.

The largest buyer was RA Capital Management, adding an estimated $50M. The largest seller was OrbiMed, cutting an estimated $8.72M.

  • 68 institutional investors held 89bio (ETNB) as of Q3 2020, up from 38 in Q2 2020.
  • Funds reported $408M of 89bio stock for Q3 2020, up 90% quarter-over-quarter.
  • 33 funds opened new 89bio positions in Q3 2020 and 3 closed out, a net change of +30 holders.
  • The largest 89bio buyer in Q3 2020 was RA Capital Management, an estimated $50M added.
  • The largest 89bio seller in Q3 2020 was OrbiMed, an estimated $8.72M sold.

Based on aggregated 13F filings for Q3 2020.